MedPath

NMPA Approvals

Chinese National Medical Products Administration approved drug approval numbers and registration information

National Medical Products Administration
China
166,322 Approvals
Showing 166201 to 166220 of 166,322 approvalsPage 8311 of 8317

根痛平胶囊

Approval Number: 国药准字Z20090563
Registration: May 27, 2019

Nisoldipine Orally Disintegrating Tablets

Approval Number: 国药准字H20080827
Registration: May 27, 2019

卡铂

Approval Number: 国药准字H20143291
Registration: May 27, 2019

氟尿苷(曾用名:氟脲苷)

Approval Number: 国药准字H20057956
Registration: May 27, 2019

薁磺酸钠

Approval Number: 国药准字H20051566
Registration: May 27, 2019

Recombinant Coagulation Factor VIII for Injection

Approval Number: S20160011
Registration: May 24, 2019

Recombinant Coagulation Factor VIII for Injection

Approval Number: S20160010
Registration: May 24, 2019

Recombinant Coagulation Factor VIII for Injection

Approval Number: S20160009
Registration: May 24, 2019

Oxymetazoline Hydrochloride Nasal Drops

Approval Number: 国药准字H20093702
Registration: May 22, 2019

Cefaclor Tablets

Approval Number: 国药准字H20093685
Registration: May 22, 2019

Bupropion Hydrochloride Sustained-release Tablets

Approval Number: 国药准字H20090221
Registration: May 22, 2019

Cefaclor for Suspension

Approval Number: 国药准字H20093686
Registration: May 22, 2019

盐酸右美托咪定

Approval Number: 国药准字H20090251
Registration: May 22, 2019

甘油

Approval Number: 国药准字H20093021
Registration: May 22, 2019

lingzhi capsule

Approval Number: 国药准字Z20093436
Registration: May 22, 2019

阿德福韦酯

Approval Number: 国药准字H20143155
Registration: May 22, 2019

Ifosfamide for Injection

Approval Number: 国药准字H20093642
Registration: May 22, 2019

Ifosfamide for Injection

Approval Number: 国药准字H20093641
Registration: May 22, 2019

蛋白琥珀酸铁

Approval Number: 国药准字H20140061
Registration: May 22, 2019

Enoxacin Eye Drops

Approval Number: 国药准字H20093699
Registration: May 22, 2019

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.